Hyponatremia in heart failure

被引：72

作者：

Farmakis, Dimitrios ^{[1
]}

Filippatos, Gerasimos ^{[1
]}

Parissis, John ^{[1
]}

Kremastinos, Dimitrios Th. ^{[1
]}

Gheorghiade, Mihai ^{[2
]}

机构：

[1] Attikon Univ Hosp, Dept Cardiol 2, Heart Failure Unit, Athens, Greece

[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

来源：

HEART FAILURE REVIEWS | 2009年 / 14卷 / 02期

关键词：

Hyponatremia; Heart failure; Vasopressin; Tolvaptan; Conivaptan; Lixivaptan; RANDOMIZED CONTROLLED-TRIAL; VASOPRESSIN ANTAGONIST; INTRAVENOUS MILRINONE; HOSPITALIZED-PATIENTS; ARGININE-VASOPRESSIN; RISK STRATIFICATION; SERUM SODIUM; TOLVAPTAN; HYPERNATREMIA; MORTALITY;

D O I：

10.1007/s10741-008-9109-7

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Hyponatremia is the most common electrolyte abnormality found in hospitalized patients with heart failure. It may occur in patients who have hypovolemic, hypervolemic, or euvolemic state. It is usually not corrected by available therapies. It is a major predictor of prognosis, and correction of hyponatremia can be effectively accomplished by vasopressin antagonists. However, it still remains to be seen whether the normalization of serum sodium with vasopressin antagonists will also lead to an improved long-term prognosis.

引用

页码：59 / 63

页数：5

共 40 条

[1]

Aquaretic efect of Lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients [J].

Abraham, WT ;

Shamshirsaz, AA ;

McFann, K ;

Oren, RM ;

Schrier, RW .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) :1615-1621

[2]

Primary care:: Hyponatremia. [J].

Adrogué, HJ ;

Madias, NE .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (21) :1581-1589

[3]

HYPONATREMIA - A PROSPECTIVE ANALYSIS OF ITS EPIDEMIOLOGY AND THE PATHOGENETIC ROLE OF VASOPRESSIN [J].

ANDERSON, RJ ;

CHUNG, HM ;

KLUGE, R ;

SCHRIER, RW .

ANNALS OF INTERNAL MEDICINE, 1985, 102 (02) :164-168

[4]

BRATER C, 2000, CHF, V6, P197

[5]

Risk stratification of in-hospital mortality in patients hospitalized for chronic congestive heart failure secondary to non-ischemic cardiomyopathy [J].

Chen, MC ;

Chang, HW ;

Cheng, CI ;

Chen, YH ;

Chai, HT .

CARDIOLOGY, 2003, 100 (03) :136-142

[6]

Correlates of major complications or death in patients admitted to the hospital with congestive heart failure [J].

Chin, MH ;

Goldman, L .

ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (16) :1814-1820

[7]

Short-term intravenous milrinone for acute exacerbation of chronic heart failure - A randomized controlled trial [J].

Cuffe, MS ;

Califf, RM ;

Adams, KF ;

Benza, R ;

Bourge, R ;

Colucci, WS ;

Massie, BM ;

O'Connor, CM ;

Pina, I ;

Quigg, R ;

Silver, MA ;

Georghiade, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (12) :1541-1547

[8]

De Luca L, 2005, AM J CARDIOL, V96, p19L, DOI 10.1016/j.amjcard.2005.09.066

[9]

PROSTAGLANDINS IN SEVERE CONGESTIVE HEART-FAILURE - RELATION TO ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM AND HYPONATREMIA [J].

DZAU, VJ ;

PACKER, M ;

LILLY, LS ;

SWARTZ, SL ;

HOLLENBERG, NK ;

WILLIAMS, GH .

NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (06) :347-352

[10]

Hyponatremia and hypernatremia - A systematic approach to causes and their correction [J].

Fall, PJ .

POSTGRADUATE MEDICINE, 2000, 107 (05) :75-82

← 1 2 3 4 →